RCMNY
CTMX icon

Rubric Capital Management (New York)’s CytomX Therapeutics CTMX Stock Holding History

Rubric Capital Management (New York)’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,406,449
Closed -$3.85M – 77
2022
Q4 		$3.85M Hold
2,406,449
– – 0.17% 77
2022
Q3 		$3.49M Hold
2,406,449
– – 0.18% 72
2022
Q2 		$4.4M Hold
2,406,449
– – 0.23% 65
2022
Q1 		$6.42M Hold
2,406,449
– – 0.3% 56
2021
Q4 		$10.4M Buy
+2,406,449
New +$14.1M 0.49% 46

Other funds holding CTMX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BCM
Bronte Capital Management Bondi Junction, Australia $928M AUM 47.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return